human-trials
EBC-46 Human Trials: Phase I/II Data, Patient Selection, and Dose-Response
An overview of QBiotics' Phase I and II human trials of tigilanol tiglate — safety profile, dose escalation, patient selection, and what the data means for the supplement category.
